Enkai Cell Technology Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 60

Employees

  • Latest Deal Type
  • Series A3

  • Latest Deal Amount
  • $13.9M

  • Investors
  • 11

Enkai Cell Technology General Information

Description

Researcher of immune cell drugs designed for tumour patients. The company focuses on applying synthetic immunology technology to NK (Natural Killer) cells to artificially create various NK cells that meet different clinical needs, enabling tumour patients to get efficient treatment with fewer side effects.

Contact Information

Website
nk-celltech.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Building 7, Lane 100, Banxia Road
  • Zhoupu Town, Pudong New Area
  • Shanghai, 200120
  • China
+86 021
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Corporate Office
  • Building 7, Lane 100, Banxia Road
  • Zhoupu Town, Pudong New Area
  • Shanghai, 200120
  • China
+86 021

Enkai Cell Technology Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Enkai Cell Technology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Early Stage VC (Series A3) 09-Jul-2025 $13.9M Completed Generating Revenue
5. Early Stage VC (Series A2) 22-Nov-2024 Completed Generating Revenue
4. Early Stage VC 03-Jun-2023 Completed Generating Revenue
3. Early Stage VC (Series A) 30-Jun-2022 Completed Generating Revenue
2. Early Stage VC 19-Nov-2021 Completed Generating Revenue
1. Corporate 23-Apr-2021 Completed Generating Revenue
To view Enkai Cell Technology’s complete valuation and funding history, request access »

Enkai Cell Technology Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Researcher of immune cell drugs designed for tumour patients. The company focuses on applying synthetic immunology techn
Drug Discovery
Shanghai, China
60 As of 2023

South San Francisco, CA
 

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Enkai Cell Technology Competitors (2)

One of Enkai Cell Technology’s 2 competitors is Nkarta Therapeutics, a Formerly VC-backed company based in South San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Nkarta Therapeutics Formerly VC-backed South San Francisco, CA
Fate Therapeutics Formerly VC-backed San Diego, CA
You’re viewing 2 of 2 competitors. Get the full list »

Enkai Cell Technology Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Enkai Cell Technology Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
3Sbio Corporation Minority
Yijin Capital Venture Capital Minority
Beijing FOF Capital Growth/Expansion Minority
Gandao Investment Holding Company Asset Manager Minority
Huagai Capital Venture Capital Minority
You’re viewing 5 of 11 investors. Get the full list »

Enkai Cell Technology FAQs

  • When was Enkai Cell Technology founded?

    Enkai Cell Technology was founded in 2020.

  • Where is Enkai Cell Technology headquartered?

    Enkai Cell Technology is headquartered in Shanghai, China.

  • What is the size of Enkai Cell Technology?

    Enkai Cell Technology has 60 total employees.

  • What industry is Enkai Cell Technology in?

    Enkai Cell Technology’s primary industry is Drug Discovery.

  • Is Enkai Cell Technology a private or public company?

    Enkai Cell Technology is a Private company.

  • What is Enkai Cell Technology’s current revenue?

    The current revenue for Enkai Cell Technology is .

  • How much funding has Enkai Cell Technology raised over time?

    Enkai Cell Technology has raised $28.9M.

  • Who are Enkai Cell Technology’s investors?

    3Sbio, Yijin Capital, Beijing FOF Capital, Gandao Investment Holding Company, and Huagai Capital are 5 of 11 investors who have invested in Enkai Cell Technology.

  • Who are Enkai Cell Technology’s competitors?

    Nkarta Therapeutics and Fate Therapeutics are competitors of Enkai Cell Technology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process